Clinical Trials Directory

Trials / Completed

CompletedNCT03450811

Effect of Inguinal Hernia Repair on Uroflowmetric Parameteres

Does the Inguinal Hernia Repair Affect Uroflowmetric Values? A Prospective Controlled Clinical Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Ankara Training and Research Hospital · Academic / Other
Sex
Male
Age
20 Years – 90 Years
Healthy volunteers
Accepted

Summary

Post operative acute urinary retension or voiding dysfunction are complications after inguinal hernia repair and they cause a great deal of discomfort and stress to patients. Furthermore, they can also increase hospital costs by increasing hospital stay, and by growing the need for outpatient appointments after an elective surgical procedure. Some studies recommend prophylactic alpha blockers to minimizing these adverse effects. Investigators aimed to determine the changes of uroflowmetric values for male patients following elective inguinal hernia repair.

Detailed description

Inguinal hernia repair is a common procedure performed in general surgery, with an annual rate of 28 per 100,000 of the population in the USA. The incidence of post operative inability voiding in males following open or laparoscopic inguinal hernia repair varies from 3 to 25%. Evaluating risk factors to reduce the occurence of this complications after one of the most commonly performed surgery by general surgeons could help reduce that high rate of that complication. Although some authors recommend prophylactic alpha blockers, there is no consensus on whether these can decrease rate of urinary retention or voiding dysfunction in male patients. In current study, investigators aimed to determinate the uroflowmetric parametric changes of patients after elective inguinal hernia repair.

Conditions

Interventions

TypeNameDescription
PROCEDUREInguinal hernia repairLichtenstein procedure or laparoscopic method (Total extraperitoneal) inguinal hernia repair

Timeline

Start date
2018-01-01
Primary completion
2018-02-20
Completion
2018-03-01
First posted
2018-03-01
Last updated
2018-03-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03450811. Inclusion in this directory is not an endorsement.